RHOH and metastatic neoplasm: Following initial H&E staining suggestive of MCC with the appropriate clinical context (i.e., a primary cutaneous tumor without evidence of metastatic disease from a noncutaneous primary tumor), IHC staining for CK20 and TTF‐1 is obtained.